Terms: = Prostate cancer AND HIP1, ILWEQ, 3092, ENSG00000127946
16 results:
1. The function of prostate Health Index in detecting clinically significant prostate cancer in the PI-RADS 3 population: a multicenter prospective study.
Zhou Y; Fu Q; Shao Z; Qi W; Zhong M; Lv G; Jiang Z; Zhu M; Wang W; Shi B; Chen S; Zhu Y
World J Urol; 2023 Feb; 41(2):455-461. PubMed ID: 36592177
[TBL] [Abstract] [Full Text] [Related]
2. UGT2B28 accelerates prostate cancer progression through stabilization of the endocytic adaptor protein hip1 regulating AR and EGFR pathways.
Lacombe L; Hovington H; Brisson H; Mehdi S; Beillevaire D; Émond JP; Wagner A; Villeneuve L; Simonyan D; Ouellet V; Barrès V; Latour M; Aprikian A; Bergeron A; Castonguay V; Couture F; Chevalier S; Brimo F; Fazli L; Fleshner N; Gleave M; Karakiewicz PI; Lattouf JB; Trudel D; van der Kwast T; Mes-Masson AM; Pouliot F; Fradet Y; Audet-Walsh E; Saad F; Guillemette C; Lévesque E
Cancer Lett; 2023 Jan; 553():215994. PubMed ID: 36343786
[TBL] [Abstract] [Full Text] [Related]
3. Nerve spare robot assisted laparoscopic prostatectomy with amniotic membranes: medium term outcomes.
Noël J; Mascarenhas A; Patel E; Reddy S; Sandri M; Bhat S; Moschovas M; Rogers T; Ahmed S; Stirt D; Patel V
J Robot Surg; 2022 Oct; 16(5):1219-1224. PubMed ID: 35015249
[TBL] [Abstract] [Full Text] [Related]
4. A novel long non-coding RNA PCLN16 facilitates androgen receptor signaling in prostate cancer.
Shi Z; Chen J; Wumaner A; Li M; Liang C; Li M
Biochem Biophys Res Commun; 2021 Jan; 537():78-84. PubMed ID: 33387886
[TBL] [Abstract] [Full Text] [Related]
5. The long non-coding RNA PCAL7 promotes prostate cancer by strengthening androgen receptor signaling.
Li Z; Teng J; Jia Z; Zhang G; Ai X
J Clin Lab Anal; 2021 Feb; 35(2):e23645. PubMed ID: 33219721
[TBL] [Abstract] [Full Text] [Related]
6. Comparison of Likert and PI-RADS version 2 MRI scoring systems for the detection of clinically significant prostate cancer.
Zawaideh JP; Sala E; Pantelidou M; Shaida N; Koo B; Caglic I; Warren AY; Carmisciano L; Saeb-Parsy K; Gnanapragasam VJ; Kastner C; Barrett T
Br J Radiol; 2020 Aug; 93(1112):20200298. PubMed ID: 32479105
[TBL] [Abstract] [Full Text] [Related]
7.
Rotundo F; Cominetti D; El Bezawy R; Percio S; Doldi V; Tortoreto M; Zuco V; Valdagni R; Zaffaroni N; Gandellini P
Cells; 2020 Feb; 9(2):. PubMed ID: 32069895
[TBL] [Abstract] [Full Text] [Related]
8. Resection of the urinary bladder for locally advanced colorectal cancer: a retrospective comparison of partial versus total cystectomy.
Kondo A; Sasaki T; Kitaguchi D; Tsukada Y; Nishizawa Y; Ito M
BMC Surg; 2019 Jun; 19(1):63. PubMed ID: 31208384
[TBL] [Abstract] [Full Text] [Related]
9. Huntingtin-interacting protein 1 phosphorylation by receptor tyrosine kinases.
Ames HM; Wang AA; Coughran A; Evaul K; Huang S; Graves CW; Soyombo AA; Ross TS
Mol Cell Biol; 2013 Sep; 33(18):3580-93. PubMed ID: 23836884
[TBL] [Abstract] [Full Text] [Related]
10. Challenges and potential solutions to meeting accrual goals in a Phase II chemoprevention trial for prostate cancer.
Kumar N; Crocker T; Smith T; Pow-Sang J; Spiess PE; Egan K; Quinn G; Schell M; Sebti S; Kazi A; Chuang T; Salup R; Helal M; Zagaja G; Trabulsi E; McLarty J; Fazili T; Williams CR; Schreiber F; Slaton J; Anderson JK
Contemp Clin Trials; 2012 Mar; 33(2):279-85. PubMed ID: 22101219
[TBL] [Abstract] [Full Text] [Related]
11. Radical prostatectomy practice in England.
Hanchanale VS; McCabe JE; Javlé P
Urol J; 2010; 7(4):243-8. PubMed ID: 21170853
[TBL] [Abstract] [Full Text] [Related]
12. Altered fibroblast growth factor receptor 4 stability promotes prostate cancer progression.
Wang J; Yu W; Cai Y; Ren C; Ittmann MM
Neoplasia; 2008 Aug; 10(8):847-56. PubMed ID: 18670643
[TBL] [Abstract] [Full Text] [Related]
13. Use of a cryptic splice site for the expression of huntingtin interacting protein 1 in select normal and neoplastic tissues.
Graves CW; Philips ST; Bradley SV; Oravecz-Wilson KI; Li L; Gauvin A; Ross TS
Cancer Res; 2008 Feb; 68(4):1064-73. PubMed ID: 18281481
[TBL] [Abstract] [Full Text] [Related]
14. Serum antibodies to huntingtin interacting protein-1: a new blood test for prostate cancer.
Bradley SV; Oravecz-Wilson KI; Bougeard G; Mizukami I; Li L; Munaco AJ; Sreekumar A; Corradetti MN; Chinnaiyan AM; Sanda MG; Ross TS
Cancer Res; 2005 May; 65(10):4126-33. PubMed ID: 15899803
[TBL] [Abstract] [Full Text] [Related]
15. Huntingtin-interacting protein 1 is overexpressed in prostate and colon cancer and is critical for cellular survival.
Rao DS; Hyun TS; Kumar PD; Mizukami IF; Rubin MA; Lucas PC; Sanda MG; Ross TS
J Clin Invest; 2002 Aug; 110(3):351-60. PubMed ID: 12163454
[TBL] [Abstract] [Full Text] [Related]
16. Synthesis and cytostatic properties of structure-simplified analogs of dolastatin 15.
Hu MK; Huang WS
J Pept Res; 1999 Dec; 54(6):460-7. PubMed ID: 10604591
[TBL] [Abstract] [Full Text] [Related]
